| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -2,230 | -1,247 | -2,315 | -7,869 |
| Bad debt expense | 30 | -41 | 76 | -246 |
| Amortization of debt discount | 96 | 118 | 123 | 225 |
| Amortization of acquired intangible assets | 1,126 | 1,065 | 1,064 | 2,129 |
| Amortization of operating lease right-of-use assets | 23 | 23 | 22 | 43 |
| Income tax payable | NaN | -1 | 0 | 11 |
| Share-based compensation | 989 | 1,775 | 1,854 | 2,659 |
| Accounts receivable | -4,761 | 11,759 | 2,415 | 5,167 |
| Inventory | -332 | -2,194 | -1,034 | -1,579 |
| Prepaid expenses and other current assets | 88 | 1,738 | -841 | -733 |
| Accounts payable | -649 | -2,706 | -1,197 | -3,296 |
| Due to related party | 17 | -300 | -85 | 312 |
| Accrued expenses | -1,465 | 6,374 | -1,362 | 5,137 |
| Accrued interest | -8 | -18 | 0 | 12 |
| Lease liabilities | -25 | -23 | -23 | -36 |
| Net cash provided by (used in) operating activities | 2,909 | -6,284 | -2,383 | -3,774 |
| Payment of debt issuance costs | NaN | 0 | 75 | NaN |
| Payment of license installment note payable | NaN | 0 | 0 | 625 |
| Proceeds from the exercise of stock options | 72 | 7 | 103 | 240 |
| Proceeds from issuance of common stock, atm offering, net of issuance costs | NaN | 5,420 | 6,891 | 4,048 |
| Issuance of common stock under espp | 148 | -1 | 119 | 99 |
| Net cash provided by financing activities | 220 | 5,426 | 7,038 | 3,762 |
| Net change in cash | 3,129 | -858 | 4,655 | -12 |
| Cash at the beginning of the period | 24,090 | 24,948 | 20,305 | NaN |
| Cash at the end of the period | 27,219 | 24,090 | 24,948 | NaN |
Journey Medical Corp (DERM)
Journey Medical Corp (DERM)